What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

Press Release Prudentia Sciences, an AI-powered technology platform for life sciences announced today its public launch, supported by $7 million in funding. The funding round was led by GV, with ...

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...

The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI). Lengthy drug development timelines and complex regulatory ...

In this guest commentary, Caleb Appleton, a principal at Bison Ventures, offers up a framework biotech founders can use to determine whether they should market their platform to others, or leverage it ...

Greater Boston's life sciences leaders will find out in 2025 if their industry can overcome its post-pandemic slump — and how ...

Indegene announced a strategic partnership with CliniOps, a leading provider of advanced digital clinical trial solutions to drive innovative digital transformation in clinical trial processes and ...

Healthcare tech company H1 picked up Ribbon Health, a provider data management software company to broaden its reach into the ...

With a client base that includes the world's top 20 pharma companies, Indegene brings a strong track record of modernizing the industry with its deep domain expertise and life sciences-contextualized ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...